Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125559322 | 12555932 | 2 | F | 20160331 | 20160722 | 20160714 | 20160730 | EXP | CN-ASTRAZENECA-2016SE38243 | ASTRAZENECA | 83.00 | YR | M | Y | 0.00000 | 20160730 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125559322 | 12555932 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | N | U | 206995 | 250 | MG | TABLET | QD | |||||
| 125559322 | 12555932 | 2 | C | LEVAMLODIPINE BESLATE | 2 | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125559322 | 12555932 | 1 | Lung adenocarcinoma |
| 125559322 | 12555932 | 2 | Blood pressure abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125559322 | 12555932 | OT |
| 125559322 | 12555932 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125559322 | 12555932 | Anaemia | |
| 125559322 | 12555932 | Benign prostatic hyperplasia | |
| 125559322 | 12555932 | Blood pressure decreased | |
| 125559322 | 12555932 | Bronchitis | |
| 125559322 | 12555932 | Cerebral atrophy | |
| 125559322 | 12555932 | Cerebral infarction | |
| 125559322 | 12555932 | Chest discomfort | |
| 125559322 | 12555932 | Coma | |
| 125559322 | 12555932 | Depressed level of consciousness | |
| 125559322 | 12555932 | Hepatic cyst | |
| 125559322 | 12555932 | Hypertension | |
| 125559322 | 12555932 | Interstitial lung disease | |
| 125559322 | 12555932 | Lacunar infarction | |
| 125559322 | 12555932 | Metastases to bone | |
| 125559322 | 12555932 | Metastases to pleura | |
| 125559322 | 12555932 | Muscular weakness | |
| 125559322 | 12555932 | Oxygen saturation decreased | |
| 125559322 | 12555932 | Pleural effusion | |
| 125559322 | 12555932 | Prostatic calcification | |
| 125559322 | 12555932 | Renal cyst | |
| 125559322 | 12555932 | Respiratory failure | |
| 125559322 | 12555932 | Tachypnoea | |
| 125559322 | 12555932 | White matter lesion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125559322 | 12555932 | 1 | 20151228 | 0 |